Skip to main content
Publications
Margulis A , Andrews E, Hernandez-Diaz S, Magyari M, Rivero-Ferrer E , Bader-Weder S, Evershed J, Garas M, Wang Q, Wormser D. Design of a multi-source post-marketing study to evaluate pregnancy and infant outcomes in women with multiple sclerosis who were exposed to ocrelizumab during, or within 6 months before, pregnancy . Poster presented at the 2018 American Academy of Neurology Annual Meeting; April 25, 2018. Los Angeles, CA.
Herring WL , Zhang Y, Pearson I , Tempest M, Freudensprung U, Acosta C, Hyde R, Spelman T, Butzkueven H. A cost-effectiveness analysis using real-world data from the MSBase registry: comparing natalizumab to fingolimod in patients with inadequate response to disease-modifying therapies in relapsing-remitting multiple sclerosis (RRMS) in Scotland . Poster presented at the 2018 American Academy of Neurology Annual Meeting; April 22, 2018. Los Angeles, CA. Previously presented at the 7th Joint ECTRIMS-ACTRIMS Meeting.
Lucas A , Wilson M , Wasserman M, Jones D, Vyse A, Slack M, Hilton B, Madhava H, Farkouh R. Dynamic transmission modeling of pneumococcal conjugate vaccine and potential dosing reduction in the United Kingdom . Poster presented at the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD); April 17, 2018. Melbourne, Australia.
Schraw JM, Desrosiers TA, Nembhard WN, Copeland G, Meyer RE, Brown AL, Chambers TM, Danysh HE , Sisoudiya S, Luo C, Mian A, Scheurer ME, Plon SE, Lupo PJ. A population-based assessment of cancer risk among children with non-chromosomal birth defects in 10 million live births . Poster presented at the American Association for Cancer Research (AACR) Annual Meeting 2018; April 16, 2018. Chicago, IL.
Wilson M , Wasserman M, Earnshaw S , McDade C , Pugh S, Moffatt M, Sings H, Hilton B, Farkouh R. Predicting invasive pneumococcal disease incidence: a forecasting approach . Poster presented at the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD); April 16, 2018. Melbourne, Australia.
Pollard DJ, Brennan A, Dixon S, Waugh N, Elliott J, Heller S, Lee E, Campbell M, Basarir H , White D, REPOSE group. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial . BMJ Open. 2018 Apr 7;8(4):e016766. doi: 10.1136/bmjopen-2017-016766
Fuertes E, Carsin AE , Anto JM, Bono R, Corsico AG, Demoly P, Gislason T, Gullon JA, Janson C, Jarvis D, Heinrich J, Holm M, Leynaert B, Marcon A, Martinez-Moratalla J, Nowak D, Pascual Erquicia S, Probst-Hensch NM, Raherison C, Raza W, Real FG, Russell M, Sanchez-Ramos JL, Weyler J, Garcia Aymerich J. Leisure-time vigorous physical activity is associated with better lung function: the prospective ECRHS study . Thorax. 2018 Apr;73(4):376-84. doi: 10.1136/thoraxjnl-2017-210947
Mueller N, Rojas-Rueda D, Salmon M, Martinez D , Ambros A, Brand C, de Nazelle A, Dons E, Gaupp-Berghausen M, Gerike R, Gotschi T, Iacorossi F, Panis LI, Kahlmeier S, Raser E, Nieuwenhuijsen M, PASTA consortium. Health impact assessment of cycling network expansions in European cities . Prev Med. 2018 Apr;109:62-70. doi: 10.1016/j.ypmed.2017.12.011
Gascon M, Sanchez-Benavides G, Dadvand P, Martinez D , Gramunt N, Gotsens X, Cirach M, Vert C, Molinuevo JL, Crous-Bou M, Nieuwenhuijsen M. Long-term exposure to residential green and blue spaces and anxiety and depression in adults: a cross-sectional study . Environ Res. 2018 Apr;162:231-9. doi: 10.1016/j.envres.2018.01.012
Heritier H, Vienneau D, Foraster M , Eze IC, Schaffner E, Thiesse L, Ruzdik F, Habermacher M, Kopfli M, Pieren R, Schmidt-Trucksass A, Brink M, Cajochen C, Wunderli JM, Probst-Hensch N, Roosli M. Diurnal variability of transportation noise exposure and cardiovascular mortality: a nationwide cohort study from Switzerland . Int J Hyg Environ Health. 2018 Apr;221(3):556-63. doi: 10.1016/j.ijheh.2018.02.005
Doward L , Balp MM, Twiss J , Slota C , Cryer D, Langford A, Collen R, Agashivala N, Brass C, Anstee QM, Sanyal A. Measuring what matters to patients: the development of the NASH-CHECK, a new patient-reported outcome instrument for nonalcoholic steatohepatitis . Poster presented at the 2018 EASL International Liver Conference; April 13, 2018. Paris, France. [abstract] J Hepatol. 2018 Apr; 68(Suppl 1):S570.
Patterson B, Curran D, Buck P, Varghese L, Oorschot D, Carrico J, Hicks K , Lee B, Yawn B. Cost-effectiveness of candidate adjuvanted subunit vaccine for vaccinating U.S. adults not previously vaccinated against herpes zoster . Poster presented at the 2018 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 25, 2018. Boston, MA. [abstract] J Manag Care Pharm. 2018 Apr; 24(4-a):S20.
Nagar SP , Rane PP, Fox KM, Meyers J , Davis K , Beaubrun A, Inomata H, Qian Y, Kajinami K. Treatment patterns, statin intolerance, and subsequent cardiovascular events among Japanese patients with high cardiovascular risk initiating statin therapy . Circ J. 2018 Mar 23;82(4):1008-16. doi: 10.1253/circj.CJ-17-0811